Georg Stingl
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82 publications
Correction: Consensus Recommendations for the Management of Atopic Dermatitis in the United Arab Emirates.
Journal: Dermatology and therapy
Published: October 05, 2024
Consensus Recommendations for the Management of Atopic Dermatitis in the United Arab Emirates.
Journal: Dermatology and therapy
Published: June 07, 2024
Single-cell sequencing delineates T-cell clonality and pathogenesis of the parapsoriasis disease group.
Journal: The Journal of allergy and clinical immunology
Published: March 27, 2024
Subcutaneous adipose tissue: Implications in dermatological diseases and beyond.
Journal: Allergy
Published: February 08, 2024
Development of a Cellular Assay as a Personalized Model for Testing Chronic Wound Therapeutics.
Journal: The Journal of investigative dermatology
Published: August 25, 2023
The vIGA-AD scale for atopic dermatitis: Uptake in the past 5 years and position of the International Eczema Council.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: June 16, 2023
Pioneers in Dermatology and Venereology: an interview with Professor Georg Stingl.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: June 17, 2022
IgE Depletion with Ligelizumab Does Not Significantly Improve Clinical Symptoms in Patients with Moderate-to-Severe Atopic Dermatitis.
Journal: The Journal of investigative dermatology
Published: April 13, 2022
Safety of Brodalumab in Plaque Psoriasis: Integrated Pooled Data from Five Clinical Trials.
Journal: Acta dermato-venereologica
Published: February 22, 2022
Training Physician‒Scientists in Dermatology in Austria.
Journal: JID innovations : skin science from molecules to population health
Published: January 24, 2022
Topical niclosamide (ATx201) reduces Staphylococcus aureus colonization and increases Shannon diversity of the skin microbiome in atopic dermatitis patients in a randomized, double-blind, placebo-controlled Phase 2 trial.
Journal: Clinical and translational medicine
Published: October 26, 2021
Last Updated: 09/26/2026